<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Clinical research / Clinical pharmacology / Drug safety / Healthcare quality / Pharmacovigilance / Clinical trial / Medical device / Pharmaceutical industry in China / Adverse effect
Date: 2016-07-29 02:05:14
Pharmaceuticals policy
Clinical research
Clinical pharmacology
Drug safety
Healthcare quality
Pharmacovigilance
Clinical trial
Medical device
Pharmaceutical industry in China
Adverse effect

Microsoft Word - GVP遵守通知.doc

Add to Reading List

Source URL: www.pmda.go.jp

Download Document from Source Website

File Size: 63,11 KB

Share Document on Facebook

Similar Documents

Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re

DocID: 1vpEW - View Document

Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie

DocID: 1v4Ie - View Document

Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU

DocID: 1uY7F - View Document

PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE   

DocID: 1uOXD - View Document

Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa

DocID: 1uKFW - View Document